Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

JHL Biotech Wuhan Manufacturing Facility Built in 11 Days Now Operational

publication date: Feb 26, 2016
JHL Biotech, a Taiwan and China biotech, completed "mechanical construction" of its Wuhan biotech manufacturing facility, located in Biolake Park. The building itself is a prefabricated building made by GE Healthcare, complete with equipment, which was assembled in eleven days. The past four months have been spent getting the plant running. JHL will use the Wuhan facility for cell line development, process development, and cGMP manufacturing of its late-stage clinical and commercial biosimilar products. The company will also offer contract manufacturing on a limited basis. More details....

Stock Symbols: (TPEX: 6540) (NYSE: GE)

Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here